Live Breaking News & Updates on Lindy Durrant

Stay updated with breaking news from Lindy durrant. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Scancell receives approval to expand ModiFY cancer trial

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF) has received approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) to expand its ModiFY. ....

Lindy-durrant , Healthcare-products-regulatory-agency , Scancell-holdings , Professor-lindy ,

Scancell : Interim Report 31st October 2023

CHIEF EXECUTIVE OFFICER S STATEMENT

I am pleased to report the Group s interim results for the six-month period ended 31 October 2023. During the period, Scancell. ....

United-kingdom , Lindy-durrant , Scancell-moditope , Scancell-avidimab , Scancell-immunobody , Company-moditope , Scancell-holdings , Registrar-of-companies , European-union , Convertible-loan-notes , Financial-position , Derivative-liabilities

SCIB1 Plus Nivolumab/Ipilimumab Generates ORR of 85% in Advanced Unresectable Melanoma

SCIB1 plus nivolumab and ipilimumab elicited responses in patients with advanced, unresectable melanoma. ....

Nottingham , United-kingdom , Lindy-durrant , University-of-nottingham , Academic-department-of-clinical-oncology , Academic-department , Clinical-oncology , Scib1 , Nivolumab , Ipilimumab , Melanoma ,

Scancell Holdings doses first patient with iSCIB1+

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF), a developer of immunotherapies for cancer and infectious diseases, has reached a pivotal milestone in its. ....

Ls-prasad-kellati , Lindy-durrant , Scancell-avidimab , Scancell-holdings , Royal-preston ,

Investegate | Company Announcement

Investegate announcements from Scancell Attendance at Upcoming Conferences ....

Germany , United-kingdom , London , City-of , Spain , Samantha-paston , Nextgen-multispecifics , Freddy-crossley-emma-earl , Nick-adams-harland , Poonam-vagehla , Nicholas-moore-samira-essebiyea , Jean-michel-coss